Our experiments show that N/OFQ can inhibit CGRP release, through inhibitory GPCR signaling at the tumor innervating terminals; limiting CGRP neurotransmission prevents the previously described RAMP1-mediated immunosuppression. This evidence concerns the gene RAMP1 and neoplasm.